Mergers & Acquisitions

  • September 25, 2026

    V&E Guides Energy Sector Water Solutions Biz On $700M Buy

    Vinson & Elkins LLP is representing Select Water Solutions on its agreement to acquire private water infrastructure company Pilot Water Solutions for $700 million in cash and stock.

  • September 25, 2026

    Oil Producer Capricorn Accepts $436M Genel Bid Over DNO's

    Scottish oil producer Capricorn said Friday it has agreed to be acquired by London-based Genel Energy for approximately $436 million, scrapping its recent backing of a $396 million bid from Norway's DNO ASA.

  • September 24, 2026

    Paramount Judge Won't 'Rubber Stamp' States' Merger Deal

    A California federal judge questioned state enforcers Thursday about the details of their proposed settlement to resolve antitrust litigation challenging Paramount Skydance's planned $110 billion purchase of Warner Bros. Discovery, telling counsel, "The court isn't a rubber stamp," and "I've got questions, and I'm not the only one."

  • September 24, 2026

    PE Funds Use AI To Tailor Strategies Amid Heavy Competition

    Almost all U.S. private equity firms expect artificial intelligence to fundamentally change their investment strategies, according to a new BDO survey, as funds apply the technology across every stage of the deal cycle, from deal sourcing to diligence.

  • September 24, 2026

    Trump's Antitrust Pick Advances Amid Independence Worries

    President Donald Trump's pick to lead the antitrust division at the U.S. Department of Justice advanced to the Senate floor on Thursday, despite Democratic concerns about agency independence.

  • September 24, 2026

    Holland & Knight Hires Defense Lobbyist As Partner In DC

    A former U.S. Department of Defense senior official, who has more than 15 years of national security, economic security and government affairs experience as an attorney, lobbyist, regulator and diplomat, has joined Holland & Knight LLP, the firm recently announced.

  • September 24, 2026

    PE And Activist-Driven Moves Lead The Week's Deal Rumors

    Activist investors are turning up the pressure on companies including Six Flags Entertainment and Knife River, while private equity firms GTCR and Reverence Capital are weighing a sale of asset manager Allspring Global Investments, and Clayton Dubilier & Rice and Warburg Pincus are in talks to jointly acquire Canaccord Wealth.

  • September 24, 2026

    SPAC Settlements Drove Down Chancery Deal Values In 2025

    A surge in the number of settlements in the Delaware Chancery Court last year was driven by the end of litigation against special purpose acquisition vehicles, but settling investors received less money than at any point in the past five years, Cornerstone Research has said in a new report.

  • September 24, 2026

    Wachtell-Advised People Scraps $18B Take-Private MGM Bid

    People Inc. said it has withdrawn a June proposal to purchase all public shares of MGM Resorts International and take the company private, with advice from Wachtell Lipton Rosen & Katz. 

  • September 24, 2026

    Bredin Prat, Boyanov Advise Schneider On €1.2B Acquisition

    French multinational Schneider Electric said Thursday it plans to buy Bulgarian smart-home device maker Shelly Group in a cash deal worth approximately €1.2 billion ($1.4 billion), a deal it expects to improve how buildings monitor and manage energy use.

  • September 23, 2026

    Microsoft Heads Face Derivative Action Over Inflection AI Deal

    Three Microsoft Corp. investors filed a shareholder derivative suit in Washington state court Monday over claims the company's leaders wrongfully approved a March 2024 licensing agreement with Inflection AI Inc. aimed at bailing out Microsoft co-founder Bill Gates and entrepreneur Reid Hoffman after their investments in the startup soured.

  • September 23, 2026

    Curium Resets FTC Clock On $8B Lantheus Take-Private Deal

    Private equity-backed radiopharmaceutical company Curium reset the clock for the Federal Trade Commission's 30-day review of its plan to acquire fellow radiopharmaceutical company Lantheus Holdings Inc. in an $8 billion take-private deal.

  • September 23, 2026

    Vividion Investor Wants IP Suit Over $2B Bayer Deal Revived

    CHP III LP urged the Delaware Supreme Court on Wednesday to revive its suit over allegedly diverted intellectual property in Vividion Therapeutics Inc.'s $2 billion sale to Bayer Corp., while the defendants argued the investor is trying to turn a corporate injury into a direct stockholder claim that did not survive the merger.

  • September 23, 2026

    Spirit Airlines Gets OK To Sell 27 Planes For $668M In Ch. 11

    Spirit Airlines on Wednesday secured a New York bankruptcy judge's approval to sell 27 airplanes to two buyers for a combined $668 million.

  • September 23, 2026

    3 Firms Steer Royal Caribbean, Sandals' $3B Resort Deal

    Royal Caribbean Group said Wednesday it has agreed to invest about $3 billion for a 50% stake in a joint venture with Sandals Resorts, expanding the cruise operator's business into the all-inclusive resort market.

  • September 23, 2026

    Genesis Healthcare Reports Last-Minute Facility Sale Snags

    Genesis Healthcare and the winning bidder for its 175 nursing homes told a Texas bankruptcy judge Wednesday they have fallen into a disagreement over $100 million of the $1 billion purchase price with the deadline to close the sale a week away.

  • September 23, 2026

    FedEx-Led €7.8B Acquisition Of InPost Wins Approvals

    FedEx and U.S. private equity firm Advent International said Wednesday that their approximately €7.8 billion ($8.9 billion) offer to acquire parcel locker business InPost has cleared all the necessary conditions required for the transaction.

  • September 23, 2026

    Zurich Wins Court OK For £8.2B Takeover Of Beazley

    A London court has given the green light for Zurich's £8.2 billion ($10.9 billion) cash takeover offer for Beazley, the British insurer has said, clearing the way for the deal to wrap up in October.

  • September 23, 2026

    Dutch Biz Arcadis Digs In Heels As Canadian Rival Pulls Offer

    Arcadis reiterated Wednesday that rival WSP's estimated €4.7 billion ($5.4 billion) takeover offer undervalued the Dutch engineering consultancy, a day after the Canadian bidder said it would not pursue its proposal.

  • September 22, 2026

    4 Flashpoints In FDIC's Bid To Revamp Bank Merger Reviews

    The Federal Deposit Insurance Corp.'s new plan to overhaul its bank merger review process is aimed at delivering faster, more predictable decisions on deals, but some of its key provisions could spark friction as banks and their critics weigh in over the coming weeks.

  • September 22, 2026

    OppFi SPAC Investors Get OK For $13M Post-IPO Flop Deal

    The Delaware Chancery Court on Tuesday approved a $13 million settlement to end litigation accusing special purpose acquisition company FG New America Acquisition Corp. and several of its executives and directors of overselling the value of merger target Opportunity Financial, whose stocks plummeted by some 80% after the take-public transaction.

  • September 22, 2026

    FTC's Ferguson: Don't Fight New Fed. Courts Merger Policy

    Federal Trade Commission Chairman Andrew Ferguson on Tuesday warned companies that fighting the FTC's shift to challenging mergers exclusively in federal court risks making "your life more difficult."

  • September 22, 2026

    Inspired Healthcare Seeks OK For $713M Asset Sale

    Inspired Healthcare on Tuesday asked a Texas bankruptcy judge to approve the sale of 30 of its senior living communities but to leave for later the question of how the $713 million in proceeds will be split among its creditors.

  • September 22, 2026

    Flyers Tell 9th Circ. Alaska-Hawaiian Merger Eroding Service

    Airline customers have told the Ninth Circuit that Alaska Airlines' 2024 acquisition of Hawaiian Airlines eroded consumer choice on numerous routes, and that a district court improperly dismissed their antitrust lawsuit with premature and flawed findings that cannot be allowed to stand.

  • September 22, 2026

    Juul Buyers Defend Antitrust Classes At 9th Circ.

    Juul buyers are defending the certification of several classes in a case over tobacco giant Altria's past investment in the e-cigarette company, telling the Ninth Circuit it does not matter if they purchased different quantities on different terms or live in different states.

Expert Analysis

  • What PE Practitioners Need To Know About New Del. ABC Act

    Author Photo

    Delaware's new Assignment for the Benefit of Creditors statute represents a structural shift in how companies backed by private equity can be wound down and provides a more streamlined tool for managing sponsor liability without the public visibility of a bankruptcy proceeding, says Evelyn Meltzer at Troutman Pepper.

  • Series

    Being A Magician Makes Me A Better Lawyer

    Author Photo

    The skills I've developed as a lifelong magician have translated directly into tangible benefits in the courtroom because performing magic and trying cases both live at the intersection of psychology, storytelling, timing and disciplined rehearsal, says Mark Dombroff at Fox Rothschild.

  • Illinois Audit Law Will Make AI Clauses Actually Enforceable

    Author Photo

    A law recently enacted in Illinois creates a first-in-the-nation requirement for artificial intelligence developers to undergo annual audits, providing objective standards that can be incorporated into private contracts and addressing the problem of defining responsible AI use, says William Tanenbaum at Moses & Singer.

  • Fiduciary Duty Risks In Continuation Vehicle Transactions

    Author Photo

    Continuation vehicle transactions have become prominent in private equity, but conflicts may arise due to transaction structures and implicate fiduciary duties, with a recent Delaware case highlighting several procedural considerations for sponsors, say attorneys at Debevoise.

  • A New Regulatory Environment For PE In Calif. Healthcare

    Author Photo

    The California Office of Health Care Affordability's proposed revisions to its cost and market impact review regulations, amid broader state scrutiny of private equity-backed healthcare arrangements, represent a qualitative shift in California's regulatory posture toward institutional healthcare investment, say attorneys at Ropes & Gray.

  • CFIUS' Mandate Misses Foreign Risk In Project Subcontracts

    Author Photo

    Recent calls for the Committee on Foreign Investment in the United States to review equity transactions like the Paramount Skydance-Warner Bros. deal miss a consequential oversight gap — CFIUS' inability to review the subcontracting layer of U.S. infrastructure projects, says Thibaut Giret at Alstef Group.

  • Series

    Bass Fishing Makes Me A Better Lawyer

    Author Photo

    Landing a trophy striped bass and closing a big deal both require cultivating the patience to finesse — not force — your way to desired outcomes, changing course when your old approach isn’t working and learning from the ones that got away, says Jon Ruiss at Alston & Bird.

  • What Consent Decree Trends Mean For Deal Clearances

    Author Photo

    With merger remedies back on the table under the current administration, an analysis of recent Federal Trade Commission and U.S. Department of Justice consent decrees reveals that prior approval and prior notice provisions are no longer a foregone conclusion, and companies may be able to negotiate narrowly tailored obligations, say attorneys at Weil.

  • How Reincorporating In Texas May Alter Earnout Disputes

    Author Photo

    While the DExit debate has focused on shareholder suits, far less attention has been paid to what reincorporating in Texas means for M&A disputes, making it particularly important to understand the nuances between Delaware and Texas earnout jurisprudence, say attorneys at Selendy Gay.

  • Roundup

    The Most Talked-About Supreme Court Decisions Of 2026

    Author Photo

    This term, 11 U.S. Supreme Court decisions quickly became hot topics among Law360's guest writers.

  • Structuring Space Nuclear Deals For Regulatory Risk

    Author Photo

    With the White House's recent focus on space nuclear power, a highly important question for companies that want to build orbital reactors, lunar surface systems or critical components is whether the transaction documents can handle foreign investment constraints, export controls and treaty-linked liability, says Kristie Blase at Frazer + Blase.

  • Texas Business Court Rulings Show Deal Terms Paramount

    Author Photo

    As the courts within the Texas Business Court system have begun reaching the substantive merits of the cases before them, they are persuasively demonstrating they will not only enforce the terms of transactions as written, but will also embrace a holistic approach to complex transaction documentation interpretation, says Christopher Pace at Winston Taylor.

  • Quantum Readiness May Paradoxically Raise Contractor Risk

    Author Photo

    The organizations best positioned for the cryptographic system migration deadlines and other requirements under President Donald Trump’s recent quantum executive orders will be those able to inventory their cryptographic dependencies while protecting their vulnerability road map from adversaries, says Jesse Lemon at The Beckage Firm.

  • Why Biotech Cos. Need Litigation Plans Before Bad News

    Author Photo

    Biotech companies should take proactive steps to respond to the growing trend of securities litigation filed against them, due to the inherently uncertain nature of their business models and heightened scrutiny of clinical trial disclosures, regulatory communications and investor-facing statements, says Wesley Horton at FBFK.

  • How Maine's Expanded Health Deal Reviews Complicate M&A

    Author Photo

    A pair of recently approved Maine competition laws establish notice and approval requirements for certain healthcare transactions and expand state antitrust oversight, creating new hurdles for dealmakers as states take a more aggressive role in policing healthcare consolidation, especially involving private equity, say attorneys at McDermott.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.